A Escudero1,2, B Ruz-Caracuel1,2, D Bueno2,3, M Martínez4, P Rubio2,3, R M Regojo5, E Antolín6, M Ybarra4, L Martínez7, J J Pozo-Kreilinger5, M D Elorza4, A Pellicer4, F Omeñaca4, A Pérez-Martínez8,9,10. 1. Institute of Medical and Molecular Genetics (INGEMM), Hospital La Paz Institute for Health Research, Madrid, Spain. 2. Translational Research in Pediatric Oncology Hematopoietic Transplantation & Cell Therapy, IdiPAZ, Madrid, Spain. 3. Department of Pediatric Hematology and Oncology, Hospital Infantil Universitario La Paz, Madrid, Spain. 4. Department of Neonatology, Hospital Infantil Universitario La Paz, Madrid, Spain. 5. Department of Pathology, Hospital Infantil Universitario La Paz, Madrid, Spain. 6. Department of Obstetrics and Gynecology, Hospital Maternal Universitario La Paz, Madrid, Spain. 7. Department of Pediatric Surgery, Hospital Infantil Universitario La Paz, Madrid, Spain. 8. Institute of Medical and Molecular Genetics (INGEMM), Hospital La Paz Institute for Health Research, Madrid, Spain. aperezmartinez@salud.madrid.org. 9. Translational Research in Pediatric Oncology Hematopoietic Transplantation & Cell Therapy, IdiPAZ, Madrid, Spain. aperezmartinez@salud.madrid.org. 10. Department of Pediatric Hematology and Oncology, Hospital Infantil Universitario La Paz, Madrid, Spain. aperezmartinez@salud.madrid.org.
Abstract
BACKGROUND: Neonatal tumors represent an extremely rare and heterogeneous disease with an unknown etiology. Due to its early onset, it has been proposed that genetic factors could play a critical role; however, germline genetic analysis is not usually performed in neonatal cancer patients PATIENTS AND METHODS: To improve the identification of cancer genetic predisposition syndromes, we retrospectively review clinical characteristics in 45 patients with confirmed tumor diagnosis before 28 days of age, and we carried out germline genetic analysis in 20 patients using next-generation sequencing and directed sequencing. RESULTS: The genetic studies did not find any germline mutation except patients diagnosed with bilateral retinoblastoma who harbored RB1 germline mutations. CONCLUSIONS: Our results suggest that genetic factors have almost no higher impact in most neonatal tumors. However, since the heterogeneity of the tumors and the small sample size analyzed, we recommend complementary and centralized germline studies to discard the early onset as an additional criterion to take into account to improve the identification of cancer genetic predisposition syndromes in neonates.
BACKGROUND: Neonatal tumors represent an extremely rare and heterogeneous disease with an unknown etiology. Due to its early onset, it has been proposed that genetic factors could play a critical role; however, germline genetic analysis is not usually performed in neonatal cancer patients PATIENTS AND METHODS: To improve the identification of cancer genetic predisposition syndromes, we retrospectively review clinical characteristics in 45 patients with confirmed tumor diagnosis before 28 days of age, and we carried out germline genetic analysis in 20 patients using next-generation sequencing and directed sequencing. RESULTS: The genetic studies did not find any germline mutation except patients diagnosed with bilateral retinoblastoma who harbored RB1 germline mutations. CONCLUSIONS: Our results suggest that genetic factors have almost no higher impact in most neonatal tumors. However, since the heterogeneity of the tumors and the small sample size analyzed, we recommend complementary and centralized germline studies to discard the early onset as an additional criterion to take into account to improve the identification of cancer genetic predisposition syndromes in neonates.
Authors: P Lichtenstein; N V Holm; P K Verkasalo; A Iliadou; J Kaprio; M Koskenvuo; E Pukkala; A Skytthe; K Hemminki Journal: N Engl J Med Date: 2000-07-13 Impact factor: 91.245
Authors: Wendy Chang; Andrew S Brohl; Rajesh Patidar; Sivasish Sindiri; Jack F Shern; Jun S Wei; Young K Song; Marielle E Yohe; Berkley Gryder; Shile Zhang; Kathleen A Calzone; Nityashree Shivaprasad; Xinyu Wen; Thomas C Badgett; Markku Miettinen; Kip R Hartman; James C League-Pascual; Toby N Trahair; Brigitte C Widemann; Melinda S Merchant; Rosandra N Kaplan; Jimmy C Lin; Javed Khan Journal: Clin Cancer Res Date: 2016-03-18 Impact factor: 12.531
Authors: Susanne N Gröbner; Barbara C Worst; Joachim Weischenfeldt; Ivo Buchhalter; Kortine Kleinheinz; Vasilisa A Rudneva; Pascal D Johann; Gnana Prakash Balasubramanian; Maia Segura-Wang; Sebastian Brabetz; Sebastian Bender; Barbara Hutter; Dominik Sturm; Elke Pfaff; Daniel Hübschmann; Gideon Zipprich; Michael Heinold; Jürgen Eils; Christian Lawerenz; Serap Erkek; Sander Lambo; Sebastian Waszak; Claudia Blattmann; Arndt Borkhardt; Michaela Kuhlen; Angelika Eggert; Simone Fulda; Manfred Gessler; Jenny Wegert; Roland Kappler; Daniel Baumhoer; Stefan Burdach; Renate Kirschner-Schwabe; Udo Kontny; Andreas E Kulozik; Dietmar Lohmann; Simone Hettmer; Cornelia Eckert; Stefan Bielack; Michaela Nathrath; Charlotte Niemeyer; Günther H Richter; Johannes Schulte; Reiner Siebert; Frank Westermann; Jan J Molenaar; Gilles Vassal; Hendrik Witt; Birgit Burkhardt; Christian P Kratz; Olaf Witt; Cornelis M van Tilburg; Christof M Kramm; Gudrun Fleischhack; Uta Dirksen; Stefan Rutkowski; Michael Frühwald; Katja von Hoff; Stephan Wolf; Thomas Klingebiel; Ewa Koscielniak; Pablo Landgraf; Jan Koster; Adam C Resnick; Jinghui Zhang; Yanling Liu; Xin Zhou; Angela J Waanders; Danny A Zwijnenburg; Pichai Raman; Benedikt Brors; Ursula D Weber; Paul A Northcott; Kristian W Pajtler; Marcel Kool; Rosario M Piro; Jan O Korbel; Matthias Schlesner; Roland Eils; David T W Jones; Peter Lichter; Lukas Chavez; Marc Zapatka; Stefan M Pfister Journal: Nature Date: 2018-02-28 Impact factor: 49.962
Authors: Marjolijn C J Jongmans; Jan L C M Loeffen; Esmé Waanders; Peter M Hoogerbrugge; Marjolijn J L Ligtenberg; Roland P Kuiper; Nicoline Hoogerbrugge Journal: Eur J Med Genet Date: 2016-01-26 Impact factor: 2.708
Authors: Jinghui Zhang; Michael F Walsh; Gang Wu; Kim E Nichols; Michael N Edmonson; Tanja A Gruber; John Easton; Dale Hedges; Xiaotu Ma; Xin Zhou; Donald A Yergeau; Mark R Wilkinson; Bhavin Vadodaria; Xiang Chen; Rose B McGee; Stacy Hines-Dowell; Regina Nuccio; Emily Quinn; Sheila A Shurtleff; Michael Rusch; Aman Patel; Jared B Becksfort; Shuoguo Wang; Meaghann S Weaver; Li Ding; Elaine R Mardis; Richard K Wilson; Amar Gajjar; David W Ellison; Alberto S Pappo; Ching-Hon Pui; James R Downing Journal: N Engl J Med Date: 2015-11-18 Impact factor: 91.245
Authors: D Williams Parsons; Angshumoy Roy; Yaping Yang; Tao Wang; Sarah Scollon; Katie Bergstrom; Robin A Kerstein; Stephanie Gutierrez; Andrea K Petersen; Abhishek Bavle; Frank Y Lin; Dolores H López-Terrada; Federico A Monzon; M John Hicks; Karen W Eldin; Norma M Quintanilla; Adekunle M Adesina; Carrie A Mohila; William Whitehead; Andrew Jea; Sanjeev A Vasudevan; Jed G Nuchtern; Uma Ramamurthy; Amy L McGuire; Susan G Hilsenbeck; Jeffrey G Reid; Donna M Muzny; David A Wheeler; Stacey L Berg; Murali M Chintagumpala; Christine M Eng; Richard A Gibbs; Sharon E Plon Journal: JAMA Oncol Date: 2016-05-01 Impact factor: 31.777